articaine hydrochloride; epinephrine bitartrate · Pierrel · NDA 022466
Orabloc
Earliest generic entry, as listed · earliest of 2 marketed strengths
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 2
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 022466 · 001 · RLD | injectable, injection | 4%;EQ 0.009MG BASE/1.8ML (EQ 0.005MG BASE/ML) | open |
| 022466 · 002 · RLD | injectable, injection | 4%;EQ 0.018MG BASE/1.8ML (EQ 0.01MG BASE/ML) | open |